58 related articles for article (PubMed ID: 38485838)
1. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
2. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
Hu Q; Tai S; Wang J
Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis.
Manoochehrabadi S; Talebi M; Pashaiefar H; Ghafouri-Fard S; Vaezi M; Omrani MD; Ahmadvand M
Blood Res; 2024 Feb; 59(1):4. PubMed ID: 38485838
[TBL] [Abstract][Full Text] [Related]
4. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
5. CDC45 modulates MCM7 expression and inhibits cell proliferation by suppressing the PI3K/AKT pathway in acute myeloid leukemia.
Zhang R; Liu Z; Zhang G
Am J Transl Res; 2021; 13(9):10218-10232. PubMed ID: 34650692
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
8. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
9. Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors.
Sofi S; Mehraj U; Qayoom H; Aisha S; Almilaibary A; Alkhanani M; Mir MA
Med Oncol; 2022 Jun; 39(9):133. PubMed ID: 35723742
[TBL] [Abstract][Full Text] [Related]
10. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC.
Xu Y; Yu X; Sun Z; He Y; Guo W
Front Oncol; 2022; 12():831366. PubMed ID: 35356220
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model.
Yang L; Zhang H; Yang X; Lu T; Ma S; Cheng H; Yen K; Cheng T
Front Oncol; 2021; 11():659201. PubMed ID: 34123815
[TBL] [Abstract][Full Text] [Related]
12. Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling.
Mosquera Orgueira A; Peleteiro Raíndo A; Cid López M; Díaz Arias JÁ; González Pérez MS; Antelo Rodríguez B; Alonso Vence N; Bao Pérez L; Ferreiro Ferro R; Albors Ferreiro M; Abuín Blanco A; Fontanes Trabazo E; Cerchione C; Martinnelli G; Montesinos Fernández P; Mateo Pérez Encinas M; Luis Bello López J
Front Oncol; 2021; 11():657191. PubMed ID: 33854980
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma.
Yang C; Xie S; Wu Y; Ru G; He X; Pan HY; Wang S; Tong X
PeerJ; 2021; 9():e10824. PubMed ID: 33614286
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Antar AI; Otrock ZK; Abou Dalle I; El-Cheikh J; Bazarbachi A
Front Oncol; 2020; 10():596134. PubMed ID: 33224890
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy.
Li P; Zhong X; Zhang L; Yu Y; Niu J
Nephrology (Carlton); 2021 Mar; 26(3):262-269. PubMed ID: 33207024
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]